SCHEMBL4685201

SCHEMBL4685201

COc1ccccc1CC(=O)N1C(=O)OCC1Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
CSNK2B P67870 1/20 0.46
CSNK2A1 P68400 1/20 0.46
KDM4E B2RXH2 2/20 0.45
ALOX15 P16050 1/20 0.45
CCR3 P51677 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
CASP3 P42574 1/20 0.42
CASP7 P55210 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
NAAA Q02083 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
PARP1 P09874 1/20 0.41
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4510525 1.00 SIGMAR1 (0.47) SIGMAR1KMT2AMEN1CSNK2BCSNK2A1
SCHEMBL4515994 1.00 SIGMAR1 (0.47) SIGMAR1KMT2AMEN1CSNK2BCSNK2A1
SCHEMBL16307073 0.88 KDM4E (0.49) KMT2AMEN1CSNK2BCSNK2A1KDM4E
SCHEMBL3305638 0.88 KDM4E (0.45) KMT2AMEN1CSNK2BCSNK2A1KDM4E
SCHEMBL16307001 0.88 KDM4E (0.49) KMT2AMEN1CSNK2BCSNK2A1KDM4E
SCHEMBL3305644 0.88 KDM4E (0.45) KMT2AMEN1CSNK2BCSNK2A1KDM4E
SCHEMBL24977629 0.86 NAAA (0.45) CSNK2BCSNK2A1NAAAALDH1A1
SCHEMBL8357541 0.85 KDM4E (0.48) SIGMAR1KMT2AMEN1CSNK2BCSNK2A1
SCHEMBL31446435 0.84 CSNK2B (0.41) KMT2AMEN1CSNK2BCSNK2A1NAAA
SCHEMBL20006910 0.83 PDE4B (0.44) KMT2ACSNK2BCSNK2A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057959-A1 DNA-PK INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2016-08-24 EP disclosed
WO-2015058031-A1 DNA-PK INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-04-23 WO disclosed
EP-2841428-A1 DNA-PK INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2015-03-04 EP disclosed
WO-2013163190-A1 DNA-PK INHIBITORS VERTEX PHARMACEUTICAL INCORPORATED (US) 2013-10-31 WO disclosed
CN-101321741-A Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols WYETH CORP (US) 2008-12-10 CN disclosed
EP-1957470-A1 PROCESS FOR SELECTIVE SYNTHESIS OF ENANTIOMERS OF SUBSTITUTED 1-(2-AMINO-1-PHENYL-ETHYL)-CYCLOHEXANOLS Wyeth (US) 2008-08-20 EP disclosed
EP-1957470-A1 PROCESS FOR SELECTIVE SYNTHESIS OF ENANTIOMERS OF SUBSTITUTED 1-(2-AMINO-1-PHENYL-ETHYL)-CYCLOHEXANOLS Wyeth (US) 2008-08-20 EP disclosed
WO-2007067501-A1 PROCESS FOR SELECTIVE SYNTHESIS OF ENANTIOMERS OF SUBSTITUTED 1-(2-AMINO-1-PHENYL-ETHYL)-CYCLOHEXANOLS WYETH (US) 2007-06-14 WO disclosed
WO-2007067501-A1 PROCESS FOR SELECTIVE SYNTHESIS OF ENANTIOMERS OF SUBSTITUTED 1-(2-AMINO-1-PHENYL-ETHYL)-CYCLOHEXANOLS WYETH (US) 2007-06-14 WO disclosed